KURA ONCOLOGY INC. - COMMON STOCK

Kura Oncology Reports First Quarter 2022 Financial Results

04 май 2022 16:05:01 Источник Nasdaq GlobeNewswire

Kura Oncology to Report First Quarter 2022 Financial Results

27 апр 2022 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Emergence of Resistance to Osimertinib in Non-Small Cell Lung Cancer

08 апр 2022 13:00:00 Источник Nasdaq GlobeNewswire

Kura Oncology Announces Multiple Abstracts Accepted for Presentation at AACR Annual Meeting

08 мар 2022 17:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Participate in Two Upcoming Investor Conferences

28 фев 2022 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Fourth Quarter and Full Year 2021 Financial Results

24 фев 2022 16:03:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Report Fourth Quarter and Full Year 2021 Financial Results

17 фев 2022 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Participate in SVB Leerink Global Healthcare Conference

10 фев 2022 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Expands Leadership Team with Key Promotions

01 фев 2022 16:01:00 Источник Nasdaq GlobeNewswire

Kura Oncology Receives FDA Authorization to Proceed with Phase 1b Study of KO-539 in Acute Myeloid Leukemia

20 янв 2022 16:01:00 Источник Nasdaq GlobeNewswire

Kura Oncology Doses First Patient in Phase 1/2 Clinical Trial of Tipifarnib in Combination with Alpelisib in Head and Neck Squamous Cell Carcinoma

16 дек 2021 09:16:22 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Final Results from Phase 2 Study of Tipifarnib in T-Cell Lymphoma

13 дек 2021 10:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Preclinical Data Highlighting Synergistic Activity of Menin Inhibitor KO-539 in Combination with Venetoclax

13 дек 2021 07:00:01 Источник Nasdaq GlobeNewswire

Kura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia

24 ноя 2021 06:45:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Participate in Two Upcoming Investor Conferences

23 ноя 2021 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Third Quarter 2021 Financial Results

04 ноя 2021 16:05:02 Источник Nasdaq GlobeNewswire

Kura Oncology to Participate in Credit Suisse Healthcare Conference

02 ноя 2021 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Report Third Quarter 2021 Financial Results

28 окт 2021 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Appoints Teresa Bair as Chief Legal Officer

18 окт 2021 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Participate in Two Upcoming Investor Conferences

07 сен 2021 07:30:00 Источник Nasdaq GlobeNewswire